TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.

TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
复制标题

DOI:
10.1523/jneurosci.5894-09.2010
复制
发表时间:
2010-06-02
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
通讯作者:
Taylor JP
Taylor JP
中科院分区:
其他
文献类型:
--
作者:
Ritson GP;Custer SK;Freibaum BD;Guinto JB;Geffel D;Moore J;Tang W;Winton MJ;Neumann M;Trojanowski JQ;Lee VM;Forman MS;Taylor JP

文献摘要

被引文献

相似文献

包含体肌病伴佩吉特骨病和额颞叶痴呆(IBMPFD)是一种显性遗传性退行性疾病,由含缬氨肽蛋白(VCP)基因突变引起。VCP(小鼠p97,D. melanogaster和S.酿酒酵母)是高度保守的AAA+-ATP酶,其调节广泛的细胞过程。IBMPFD的发病机制尚不清楚。为了阐明致病机制,我们开发了一个果蝇模型的IBMPFD(突变VCP-related变性)。基于该模型的遗传筛选,我们确定了三种主要抑制变性的RNA结合蛋白;其中之一是TBPH,TAR DNA结合蛋白(TDP-43)的果蝇同源物。在这里,我们证明了VCP和TDP-43在遗传上相互作用,并且VCP中的致病突变导致TDP-43在体外和体内重新分布到细胞质中,复制了在IBMPFD和其他TDP-43蛋白病中观察到的主要病理。我们还证明,TDP-43从细胞核到细胞质的再分布足以诱导细胞毒性。此外,我们确定TDP-43中的致病突变促进了向细胞质的再分布,并增强了与VCP的遗传相互作用。总之,我们的结果表明,与VCP突变相关的变性部分是由细胞质中TDP-43的毒性功能获得介导的。我们认为这些发现可能与一系列广泛的TDP-43蛋白病的致病机制有关,包括额颞叶变性和肌萎缩侧索硬化。
Inclusion body myopathy associated with Paget’s disease of bone and frontotemporal dementia (IBMPFD) is a dominantly inherited degenerative disorder caused by mutations in the valosin-containing protein (VCP) gene. VCP (p97 in mouse, TER94 in D. melanogaster, and CDC48 in S. cerevisiae) is a highly conserved AAA+-ATPase that regulates a wide array of cellular processes. The mechanism of IBMPFD pathogenesis is unknown. To elucidate the pathogenic mechanism, we developed and characterized a Drosophila model of IBMPFD (mutant VCP–related degeneration). Based on genetic screening of this model we identified three RNA-binding proteins that dominantly suppressed degeneration; one of these was TBPH, the Drosophila homolog of TAR DNA-binding protein (TDP-43). Here we demonstrate that VCP and TDP-43 interact genetically and that disease-causing mutations in VCP lead to redistribution of TDP-43 to the cytoplasm in vitro and in vivo, replicating the major pathology observed in IBMPFD and other TDP-43 proteinopathies. We also demonstrate that TDP-43 redistribution from the nucleus to the cytoplasm is sufficient to induce cytotoxicity. Furthermore, we determined that a pathogenic mutation in TDP-43 promotes redistribution to the cytoplasm and enhances the genetic interaction with VCP. Taken together, our results show that degeneration associated with VCP mutations is mediated in part by toxic gain-of-function of TDP-43 in the cytoplasm. We suggest that these findings are likely relevant to the pathogenic mechanism of a broad array of TDP-43 proteinopathies, including frontotemporal lobar degeneration and amyotrophic lateral sclerosis.